Artemisinin derivatives and combined artemisinin therapy (ACT) may have advantages over quinoline drugs for treating severe malaria since they are fast acting and effective against quinine resistant malaria parasites. Artemisia annua and Artemisia afra show efficacy against drug-resistant malaria and schistosomiasis,
Artemisia annua and Artemisia afra have shown efficacy against RNA virus SARS-coronavirus and variants, UK, South African, P1 and Delta.
“From the common cold (rhinovirus), to uncomfortable cold sores (herpes simplex), to “the flu” (influenza), we have all experienced a viral infection during our lives. While the cold is unpleasant, some viruses are truly dangerous, and what makes viruses so frightening is the fact that there are few effective treatments for them. Most of what we can treat when we are infected with a virus are its symptoms. When that virus is the common cold, that is inconvenient. However, when the virus is something more serious, our inability to shorten its duration or reduce the damage it causes can be a matter of life and death.
This has never been as clear as it is right now, with the world in the grip of the novel coronavirus, which causes the disease known as COVID-19. This new virus (SARS-CoV2) belongs to the coronavirus family that includes SARS (Severe Acute Respiratory Syndrome), which terrified the world in 2003. As we experience a global pandemic that is claiming tens of thousands of lives, scientists are racing against the clock to develop a vaccine or treatment for this devastating coronavirus.
Fortunately, there is evidence to show that an effective treatment and even prevention may already exist in the form of Artemisia annua. This plant contains a range of active compounds that make it a naturally occurring, side-effect free, combination therapy. As seen in the scientific reports below, Artemisia annua is effective against a range of viruses, but most importantly shows considerable activity against SARS-coronavirus.” (Artemisiaannua.org)
In a recent 2021 Journal of Ethnopharamacolgy publication, suggest that the active component within Artemisia annua L is likely something besides artemisinin or is a combination of components acting synergistically to block post-entry viral infection.
Published Study Summaries
Atelier Temenos is not the author of this material. It is an independent source. Please read and use the information as needed.
Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants.
Nair MS, Huang Y, Fidock DA, Polyak SJ, Wagoner J, Towler MJ, Weathers PJ.bioRxiv. 2021 Feb 24:2021.01.08.425825. doi: 10.1101/2021.01.08.425825. Preprint.PMID: 33442683 Free PMC article.
An overview of the anti-SARS-CoV-2 properties of Artemisia annua, its antiviral action, protein-associated mechanisms, and repurposing for COVID-19 treatment.
Fuzimoto AD.J Integr Med. 2021 Jul 22:S2095-4964(21)00063-7. doi: 10.1016/j.joim.2021.07.003. Online ahead of print.PMID: 34479848 Free PMC article. Revie
Flavonoids from Artemisia annua L. as antioxidants and their potential synergism with artemisinin against malaria and cancer.
Ferreira JF, Luthria DL, Sasaki T, Heyerick A.Molecules. 2010 Apr 29;15(5):3135-70. doi: 10.3390/molecules15053135.PMID: 20657468 Free PMC article. Review.